Literature DB >> 32564145

Impact of the preoperative body composition indexes on intraoperative blood loss in patients undergoing pancreatoduodenectomy.

Kenta Ishii1, Yukihiro Yokoyama2,3, Tomoki Ebata1, Tsuyoshi Igami1, Takashi Mizuno1, Junpei Yamaguchi1, Shunsuke Onoe1, Nobuyuki Watanabe1,4, Masato Nagino1.   

Abstract

PURPOSES: This study sought to identify any significant predictors of blood loss during pancreatoduodenectomy (PD) among preoperative variables, including the body composition indexes.
METHODS: The preoperative data of patients undergoing PD were retrospectively reviewed. The objective variable was the percentage of blood loss during PD to the estimated circulating blood volume (proportional blood loss: PBL). The circulating blood volume was estimated using Nadler's formula. The total psoas area, average Hounsfield units of psoas area (psoas muscle density: PMD), and visceral to subcutaneous adipose tissue area ratio (VSR) were measured at the third vertebra using preoperative plain computed tomography images. A univariate analysis and multiple linear regression analysis for PBL were conducted using the preoperative variables.
RESULTS: A total of 415 patients were analyzed. The median PBL was 24.5%. The PMD (coefficient - 0.267; 95% CI - 0.518, - 0.015), VSR (coefficient 2.719; 95% CI 0.238, 5.201), serum albumin level (coefficient - 8.458; 95% CI - 13.02, - 3.898), neoadjuvant therapy (coefficient 9.605; 95% CI 1.722, 17.49), and prothrombin time-international normalized ratio (PT-INR, coefficient 38.63; 95% CI 10.94, 66.31) were independently associated with PBL.
CONCLUSIONS: The preoperative PMD, VSR, serum albumin level, neoadjuvant therapy, and PT-INR independently affected PBL. These factors could therefore be potential targets to reduce blood loss during PD.

Entities:  

Keywords:  Psoas muscle index; Sarcopenia; Serum albumin; Visceral to subcutaneous adipose tissue area ratio

Mesh:

Substances:

Year:  2020        PMID: 32564145     DOI: 10.1007/s00595-020-02054-y

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  29 in total

1.  The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy.

Authors:  Thomas F Seykora; Brett L Ecker; Matthew T McMillan; Laura Maggino; Joal D Beane; Zhi Ven Fong; Robert H Hollis; Nigel B Jamieson; Ammar A Javed; Stacy J Kowalsky; John W Kunstman; Giuseppe Malleo; Katherine E Poruk; Kevin Soares; Vicente Valero; Lavanniya K P Velu; Ammara A Watkins; Charles M Vollmer
Journal:  Ann Surg       Date:  2019-07       Impact factor: 12.969

2.  Pancreatoduodenectomy with portal vein resection for distal cholangiocarcinoma.

Authors:  T Maeta; T Ebata; E Hayashi; T Kawahara; S Mizuno; N Matsumoto; S Ohta; M Nagino
Journal:  Br J Surg       Date:  2017-08-07       Impact factor: 6.939

3.  Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgery.

Authors:  N Pecorelli; G Carrara; F De Cobelli; G Cristel; A Damascelli; G Balzano; L Beretta; M Braga
Journal:  Br J Surg       Date:  2016-01-18       Impact factor: 6.939

4.  A prognostic score to predict major complications after pancreaticoduodenectomy.

Authors:  Marco Braga; Giovanni Capretti; Nicolò Pecorelli; Gianpaolo Balzano; Claudio Doglioni; Riccardo Ariotti; Valerio Di Carlo
Journal:  Ann Surg       Date:  2011-11       Impact factor: 12.969

5.  Major intraoperative bleeding during pancreatoduodenectomy - preoperative biliary drainage is the only modifiable risk factor.

Authors:  Jenny Rystedt; Bobby Tingstedt; Christoph Ansorge; Johan Nilsson; Bodil Andersson
Journal:  HPB (Oxford)       Date:  2018-08-28       Impact factor: 3.647

6.  Improved survival following pancreaticoduodenectomy to treat adenocarcinoma of the pancreas: the influence of operative blood loss.

Authors:  Kevork K Kazanjian; O Joe Hines; John P Duffy; Diana Y Yoon; Galen Cortina; Howard A Reber
Journal:  Arch Surg       Date:  2008-12

7.  Prediction of pancreatic anastomotic failure after pancreatoduodenectomy: the use of preoperative, quantitative computed tomography to measure remnant pancreatic volume and body composition.

Authors:  Yujiro Kirihara; Naoki Takahashi; Yasushi Hashimoto; Guido M Sclabas; Saboor Khan; Toshiyuki Moriya; Junichi Sakagami; Marianne Huebner; Michael G Sarr; Michael B Farnell
Journal:  Ann Surg       Date:  2013-03       Impact factor: 12.969

8.  Perioperative blood transfusion is associated with decreased survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma: a multi-institutional study.

Authors:  Jeffrey M Sutton; David A Kooby; Gregory C Wilson; M Hart Squires; Dennis J Hanseman; Shishir K Maithel; David J Bentrem; Sharon M Weber; Clifford S Cho; Emily R Winslow; Charles R Scoggins; Robert C G Martin; Hong Jin Kim; Justin J Baker; Nipun B Merchant; Alexander A Parikh; Daniel E Abbott; Michael J Edwards; Syed A Ahmad
Journal:  J Gastrointest Surg       Date:  2014-06-19       Impact factor: 3.452

9.  An assessment of the necessity of transfusion during pancreatoduodenectomy.

Authors:  Amelia Ross; Somala Mohammed; George Vanburen; Eric J Silberfein; Avo Artinyan; Sally E Hodges; William E Fisher
Journal:  Surgery       Date:  2013-09       Impact factor: 3.982

10.  Radiographic sarcopenia predicts postoperative infectious complications in patients undergoing pancreaticoduodenectomy.

Authors:  Kosei Takagi; Ryuichi Yoshida; Takahito Yagi; Yuzo Umeda; Daisuke Nobuoka; Takashi Kuise; Toshiyoshi Fujiwara
Journal:  BMC Surg       Date:  2017-05-26       Impact factor: 2.102

View more
  1 in total

1.  Tranexamic ACid during PancereaticoDuodenectomy (TAC-PD): study protocol for a multicentre randomised, blind, placebo-controlled trial.

Authors:  Kenta Ishii; Yukihiro Yokoyama; Yoshihiko Yonekawa; Tomoki Ebata
Journal:  BMJ Open       Date:  2020-11-03       Impact factor: 2.692

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.